Tai-ze Yuan
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Induction Paclitaxel-Cisplatin-Capecitabine for Nasopharyngeal Carcinoma.
Journal: NEJM evidence
Published: August 25, 2026
Anxiety and depression in nasopharyngeal carcinoma patients and network analysis to identify central symptoms: A cross-sectional study from a high-incidence area.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: October 23, 2023
The Optimal Second-Line Systemic Treatment Model for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: A Bayesian Network Meta-Analysis.
Journal: Frontiers in immunology
Published: June 02, 2021
Clinical value of docetaxel plus cisplatin (TP) induction chemotherapy followed by TP concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma.
Journal: Journal of Cancer
Published: June 25, 2020
Clinical value of nedaplatin-based chemotherapy combined with radiotherapy for locoregional advanced nasopharyngeal carcinoma: a retrospective, propensity score-matched analysis.
Journal: Journal of Cancer
Published: April 16, 2020
Boron neutron capture therapy of cancer: Critical issues and future prospects.
Journal: Thoracic cancer
Published: October 08, 2019
New frontiers in proton therapy: applications in cancers.
Journal: Cancer communications (London, England)
Published: September 26, 2019
microRNA-125b reverses the multidrug resistance of nasopharyngeal carcinoma cells via targeting of Bcl-2.
Journal: Molecular medicine reports
Published: September 04, 2015
Prognostic value of kisspeptin expression in nasopharyngeal carcinoma.
Journal: The Laryngoscope
Published: May 25, 2013
Erlotinib: An enhancer of radiation therapy in nasopharyngeal carcinoma.
Journal: Experimental and therapeutic medicine
Published: March 29, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026